These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 31043606)

  • 1. Drug resistance emergence in macaques administered cabotegravir long-acting for pre-exposure prophylaxis during acute SHIV infection.
    Radzio-Basu J; Council O; Cong ME; Ruone S; Newton A; Wei X; Mitchell J; Ellis S; Petropoulos CJ; Huang W; Spreen W; Heneine W; García-Lerma JG
    Nat Commun; 2019 May; 10(1):2005. PubMed ID: 31043606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic correlates of resistance to the HIV-1 strand transfer integrase inhibitor cabotegravir.
    Rhee SY; Parkin N; Harrigan PR; Holmes S; Shafer RW
    Antiviral Res; 2022 Dec; 208():105427. PubMed ID: 36191692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral Activity of Bictegravir and Cabotegravir against Integrase Inhibitor-Resistant SIVmac239 and HIV-1.
    Hassounah SA; Alikhani A; Oliveira M; Bharaj S; Ibanescu RI; Osman N; Xu HT; Brenner BG; Mesplède T; Wainberg MA
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Acting Cabotegravir Protects Macaques Against Repeated Penile Simian-Human Immunodeficiency Virus Exposures.
    Dobard C; Makarova N; Nishiura K; Dinh C; Holder A; Sterling M; Lipscomb J; Mitchell J; Deyounks F; Garber D; Khalil G; Spreen W; Heneine W; García-Lerma JG
    J Infect Dis; 2020 Jul; 222(3):391-395. PubMed ID: 32128569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention.
    Eshleman SH; Fogel JM; Halvas EK; Piwowar-Manning E; Marzinke MA; Kofron R; Wang Z; Mellors J; McCauley M; Rinehart AR; St Clair M; Adeyeye A; Hinojosa JC; Cabello R; Middelkoop K; Hanscom B; Cohen MS; Grinsztejn B; Landovitz RJ;
    J Infect Dis; 2022 Dec; 226(12):2170-2180. PubMed ID: 36240386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel secondary mutations C56S and G149A confer resistance to HIV-1 integrase strand transfer inhibitors.
    Yoshinaga T; Seki T; Miki S; Miyamoto T; Suyama-Kagitani A; Kawauchi-Miki S; Kobayashi M; Sato A; Stewart E; Underwood M; Fujiwara T
    Antiviral Res; 2018 Apr; 152():1-9. PubMed ID: 29410019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultra-long-acting in-situ forming implants with cabotegravir protect female macaques against rectal SHIV infection.
    Young IC; Massud I; Cottrell ML; Shrivastava R; Maturavongsadit P; Prasher A; Wong-Sam A; Dinh C; Edwards T; Mrotz V; Mitchell J; Seixas JN; Pallerla A; Thorson A; Schauer A; Sykes C; De la Cruz G; Montgomery SA; Kashuba ADM; Heneine W; Dobard CW; Kovarova M; Garcia JV; García-Lerma JG; Benhabbour SR
    Nat Commun; 2023 Feb; 14(1):708. PubMed ID: 36759645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cabotegravir long acting injection protects macaques against intravenous challenge with SIVmac251.
    Andrews CD; Bernard LS; Poon AY; Mohri H; Gettie N; Spreen WR; Gettie A; Russell-Lodrigue K; Blanchard J; Hong Z; Ho DD; Markowitz M
    AIDS; 2017 Feb; 31(4):461-467. PubMed ID: 27902508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dolutegravir Monotherapy of Simian Immunodeficiency Virus-Infected Macaques Selects for Several Patterns of Resistance Mutations with Variable Virological Outcomes.
    Van Rompay KKA; Hassounah S; Keele BF; Lifson JD; Ardeshir A; Watanabe J; Pham HT; Chertova E; Sowder R; Balzarini J; Mesplède T; Wainberg MA
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30381490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge.
    Andrews CD; Yueh YL; Spreen WR; St Bernard L; Boente-Carrera M; Rodriguez K; Gettie A; Russell-Lodrigue K; Blanchard J; Ford S; Mohri H; Cheng-Mayer C; Hong Z; Ho DD; Markowitz M
    Sci Transl Med; 2015 Jan; 7(270):270ra4. PubMed ID: 25589630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Acting Injectable Cabotegravir for HIV Prevention: What Do We Know and Need to Know about the Risks and Consequences of Cabotegravir Resistance?
    Parikh UM; Koss CA; Mellors JW
    Curr HIV/AIDS Rep; 2022 Oct; 19(5):384-393. PubMed ID: 36112336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cabotegravir in the treatment and prevention of Human Immunodeficiency Virus-1.
    McPherson TD; Sobieszczyk ME; Markowitz M
    Expert Opin Investig Drugs; 2018 Apr; 27(4):413-420. PubMed ID: 29633869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-acting integrase inhibitor GSK744 protects macaques from repeated intravaginal SHIV challenge.
    Radzio J; Spreen W; Yueh YL; Mitchell J; Jenkins L; García-Lerma JG; Heneine W
    Sci Transl Med; 2015 Jan; 7(270):270ra5. PubMed ID: 25589631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral Drug Activity in Macaques Infected during Pre-Exposure Prophylaxis Has a Transient Effect on Cell-Associated SHIV DNA Reservoirs.
    Cong ME; Pau CP; Heneine W; García-Lerma JG
    PLoS One; 2016; 11(11):e0164821. PubMed ID: 27806064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting integrase inhibitor protects macaques from intrarectal simian/human immunodeficiency virus.
    Andrews CD; Spreen WR; Mohri H; Moss L; Ford S; Gettie A; Russell-Lodrigue K; Bohm RP; Cheng-Mayer C; Hong Z; Markowitz M; Ho DD
    Science; 2014 Mar; 343(6175):1151-4. PubMed ID: 24594934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexually transmitted infections and depot medroxyprogesterone acetate do not impact protection from simian HIV acquisition by long-acting cabotegravir in macaques.
    Vishwanathan SA; Zhao C; Luthra R; Khalil GK; Morris MM; Dinh C; Gary MJ; Mitchell J; Spreen WR; Pereira LE; Heneine W; García-Lerma JG; McNicholl JM
    AIDS; 2022 Feb; 36(2):169-176. PubMed ID: 34482355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the L74I Polymorphism on Fitness of Cabotegravir-Resistant Variants of Human Immunodeficiency Virus 1 Subtype A6.
    Hu Z; Cordwell T; Nguyen H; Li J; Jeffrey JL; Kuritzkes DR
    J Infect Dis; 2023 Nov; 228(10):1352-1356. PubMed ID: 37497681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postexposure protection of macaques from vaginal SHIV infection by topical integrase inhibitors.
    Dobard C; Sharma S; Parikh UM; West R; Taylor A; Martin A; Pau CP; Hanson DL; Lipscomb J; Smith J; Novembre F; Hazuda D; Garcia-Lerma JG; Heneine W
    Sci Transl Med; 2014 Mar; 6(227):227ra35. PubMed ID: 24622515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study.
    Smith J; Bansi-Matharu L; Cambiano V; Dimitrov D; Bershteyn A; van de Vijver D; Kripke K; Revill P; Boily MC; Meyer-Rath G; Taramusi I; Lundgren JD; van Oosterhout JJ; Kuritzkes D; Schaefer R; Siedner MJ; Schapiro J; Delany-Moretlwe S; Landovitz RJ; Flexner C; Jordan M; Venter F; Radebe M; Ripin D; Jenkins S; Resar D; Amole C; Shahmanesh M; Gupta RK; Raizes E; Johnson C; Inzaule S; Shafer R; Warren M; Stansfield S; Paredes R; Phillips AN;
    Lancet HIV; 2023 Apr; 10(4):e254-e265. PubMed ID: 36642087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Frequency of Drug-Resistant Variants Selected by Long-Acting Rilpivirine in Macaques Infected with Simian Immunodeficiency Virus Containing HIV-1 Reverse Transcriptase.
    Melody K; McBeth S; Kline C; Kashuba AD; Mellors JW; Ambrose Z
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7762-70. PubMed ID: 26438501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.